CBTF 122 is a subunit of the Xenopus CCAAT box transcription factor complex and a member of a family of double-stranded RNA-binding proteins that function in both transcriptional and post-transcriptional control. Here we identify a region of CBTF 122 containing the double-stranded RNA-binding domains that is capable of binding either RNA or DNA. We show that these domains bind A-form DNA in preference to B-form DNA and that the ؊59 to ؊31 region of the GATA-2 promoter (an in vivo target of CCAAT box transcription factor) adopts a partial A-form structure. Mutations in the RNAbinding domains that inhibit RNA binding also affect DNA binding in vitro. In addition, these mutations alter the ability of CBTF 122 fusions with engrailed transcription repressor and VP16 transcription activator domains to regulate transcription of the GATA-2 gene in vivo. These data support the hypothesis that the doublestranded RNA-binding domains of this family of proteins are important for their DNA binding both in vitro and in vivo.The 122-kDa subunit of the Xenopus CCAAT box transcription factor CBTF 122 (also known as 4F and ubp4) belongs to a family of double-stranded RNA-binding domain (dsRBD) 1 containing proteins implicated in a variety of cellular processes. CBTF 122 and its splice variant CBTF 98 have been identified as subunits of CBTF, a transcription factor that activates the GATA-2 gene both in oocytes and zygotically at the start of gastrulation (1, 2). Homologues of CBTF 122 have been identified mainly through their affinity for RNA and include NF90 (also known as DRBP76 and NFAR1), NF110, TCP80, ILF3 and MPP4 in humans (3), SPNR and ILF3 in mice (4), and p74 and ILF3 in rats (5). It is now clear that many of the human homologues arise from alternative splicing of transcripts from the ILF3 locus (6, 7).The functions assigned to these related proteins include the regulation of both transcription and mRNA stability. For example, the transcript levels of more than 90 genes, most of which are known to be regulated by type I interferons, were altered by expression of NF90, suggesting that NF90 has a role in mediating the antiviral response (8). However, it is unclear whether these changes are a result of transcriptional or posttranscriptional mechanisms. By contrast, specific regulation of interleukin-2 levels by NF90 is clearly dependent upon its stabilization of interleukin-2 mRNA (9). In transcriptional terms, the human homologues of CBTF 98